Caudill Cortney — SEC Form 4 filings
SEC reporting owner CIK 2090209. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-10.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-10-06 to 2026-03-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 33,120 shares, $2,233,065 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 17,900 shares @ $67.75 ($1,212,743) in HALOZYME THERAPEUTICS, INC., filed 2026-03-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF OPERATING OFFICER | 5 | — | 4 legs · 33,120 sh · $2,233,065 | 15 |
Form 4 filings — Caudill Cortney
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-10 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 20,000 @ $33.51 · Sale (S): 17,900 @ $67.75 · Sale (S): 2,100 @ $68.25 · Option exercise (M): 1,546 @ $33.51 · Sale (S): 8,857 @ $67.64 · Option exercise (M): 20,000 (derivative) @ $33.51 · +1 more | EDGAR |
| 2026-02-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 2,666 @ $0 · Tax withholding (F): 1,037 @ $70.98 · Option exercise (M): 2,666 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 14,047 (derivative) @ $0 · Grant/award (A): 13,047 (derivative) @ $0 · Grant/award (A): 2,403 (derivative) @ $0 · Grant/award (A): 14,751 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 9,326 @ $0 · Sale (S): 4,263 @ $65.19 · Option exercise (M): 9,326 (derivative) @ $0 | EDGAR |
| 2025-10-06 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 9,031 (derivative) @ $0 · Grant/award (A): 3,625 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2090209 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →